The intraocular lens market is projected to reach USD 6.17 billion by 2030 from USD 4.62 billion in 2025, at a CAGR of 6.0% during the forecast period. Market growth is primarily driven by the increasing prevalence of cataracts, the growing aging population, and advancements in premium lenses. However, challenges include high procedure costs, limited reimbursement in some areas, and variability in surgeon preferences.
Prominent players in the intraocular lens market are Alcon (US), Johnson & Johnson Vision Care, Inc. (US), Carl Zeiss Meditec AG (Germany), HOYA Corporation (Japan), Bausch + Lomb (US), Santen Pharmaceutical Co., Ltd. (Japan), NIDEK CO., LTD. (Japan), Lenstec, Inc. (US), Rayner Group (England), BVI (US), OPHTEC B.V. (Netherlands), SAV-IOL SA (Switzerland), Appasamy Associates Private Limited (India), Atia Vision, Inc. (US), and Biotech (Switzerland), among others. These players have adopted various growth strategies, including product launches, acquisitions, and expansions, to increase their presence and reach in the intraocular lens market.
To know about the assumptions considered for the study download the pdf brochure
In April 2025, Alcon launched the CLAREON PanOptix Pro trifocal IOL, which features proprietary ENLIGHTEN NXT optical technology delivering 94% light utilization and half the light scatter of its predecessor. The new lens offers enhanced image contrast and uninterrupted vision across distance and near, reinforcing Alcon's leadership in premium IOL innovation.
In September 2024, Johnson & Johnson Vision Care, Inc. launched the TECNIS Odyssey IOL, a next-generation full-range intraocular lens that provides precise vision at all distances and under any lighting conditions. The lens enhances visual clarity and consistency for cataract patients, reinforcing J&J’s leadership in advanced presbyopia-correcting IOL technology.
In January 2023, Bausch + Lomb acquired AcuFocus, an ophthalmic medical device company specializing in the development of advanced small-aperture intraocular technology to address diverse unmet needs in eye care.
Alcon
Alcon holds a leading position in the intraocular lens market and has a global footprint in over 100 countries, maximizing the potential of its commercialized products and product pipeline. The company offers a diverse range of contact lenses, including reusable, color-enhancing, daily disposable, dry eye remedies, and lens care products. Alcon offers a comprehensive range of surgical instruments and equipment for cataracts, retinal disorders, and refractive procedures, including cutting-edge intraocular lenses and surgical instruments.
Johnson & Johnson Vision Care, Inc.
The company’s broad product portfolio is its key strength. Johnson & Johnson markets a range of contact and intraocular lenses through its subsidiary, Vision Care, and this subsidiary achieved a sales increase in 2024. J&J provides a comprehensive range of IOLs, including advanced technologies like aspheric and toric lenses, accommodating IOLs, and presbyopia-correcting IOLs. It has built a strong reputation for quality and innovation within the ophthalmic industry. Its IOL brands, such as Tecnis and AcrySof, are well-recognized by ophthalmologists worldwide.
HOYA Corporation
HOYA is a leading provider of contact lenses, eyeglass lenses, and IOLs. The company maintains a strong presence in the Americas, Europe, Asia Pacific, the Middle East, and Africa, supported by an extensive network of distributors. Strong expansion strategies in potential international markets have enabled it to expand in more than 156 countries worldwide. It offers a wide range of IOLs and contact lenses. It also provides vision care and surgical instruments. To maintain its leading position in the intraocular lens market, the company mainly focuses on product launches, acquisitions, and joint ventures.
Market Ranking
The intraocular lens market is consolidated, with prominent players accounting for 77.9% of the total market share in 2024. Some of the players dominating the market include Alcon, Johnson & Johnson Vision Care, Inc., HOYA Corporation, Carl Zeiss Meditec AG, and Bausch + Lomb, among others.
The prominent players in the intraocular lens market are primarily based in developed regions, including North America, Europe, and the Asia Pacific. However, in recent years, several smaller players catering to intraocular lenses have emerged from niche markets and are competing with global players based on product scope and innovation. The lucrative growth opportunities in the Asia Pacific market are encouraging market players to strengthen their presence in this region.
Related Reports:
Intraocular Lens Market by Type (Monofocal IOLs (Spheric Monofocal IOLs), Premium IOLs (Accommodating IOLs)), Material (Hydrophobic Acrylic IOLs, PolyMethylMethAcrylate, Silicon IOLs), Application (Presbyopia), End User (Hospitals) - Global Forecast to 2030
Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA : 1-888-600-6441
sales@marketsandmarkets.com
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.
SEND ME A FREE SAMPLE